时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||||
---|---|---|---|---|---|---|---|---|
08:00-08:10 | 致辞 |
致辞 |
|
|||||
08:10-08:30 | 专题发言 |
甲状腺穿刺细胞学 |
|
|||||
08:30-08:50 | 专题发言 |
子宫癌肉瘤在宫颈TCT中可能出现的异常细胞形态 |
|
|||||
08:50-08:58 | 发言交流 |
EUS-FNA诊断胰腺原发Ewing肉瘤的细胞病理学探讨 |
|
|||||
08:58-09:06 | 发言交流 |
甲状腺透明变梁状肿瘤的细针穿刺细胞病理学特征 |
|
|||||
09:06-09:14 | 发言交流 |
针吸细胞块诊断腺泡状软组织肉瘤 |
|
|||||
09:14-09:22 | 发言交流 |
甲状腺细针穿刺不宜诊断标本行 BRAF 检测的意义 |
|
|||||
09:22-09:30 | 发言交流 |
肺细针穿刺细胞学粘液腺癌的诊断 |
|
|||||
09:30-09:38 | 发言交流 |
A familial case of multiple endocrine neoplasia 2A with medullary thyroid carcinoma and phaeochromocytoma: from morphology to genetic alterations penetration in two generations of a family |
|
|||||
09:38-09:46 | 发言交流 |
2021年我院宫颈液基细胞学诊断质控数据统计与分析 |
|
|||||
09:46-09:54 | 发言交流 |
27811例妊娠期妇女宫颈癌筛查临床病理分析 |
|
|||||
09:54-10:02 | 发言交流 |
Prior cytology and high-risk human papillomavirus testing in 1067 patients with endocervical adenocarcinoma or adenocarcinoma in situ |
|
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
10:12-10:32 | 专题发言 |
The Paris System for Reporting Urinary Cytology 2022 |
|
|||
10:32-10:40 | 发言交流 |
流式细胞术在非霍奇金淋巴瘤累及脱落细胞学样本中的应用 |
|
|||
10:40-10:48 | 发言交流 |
浆膜腔积液肉瘤型间皮瘤一例伴文献复习 |
|
|||
10:48-10:56 | 发言交流 |
浆膜腔积液上皮样血管肉瘤的细胞学诊断分析 |
|
|||
10:56-11:04 | 发言交流 |
Cytologic Features of SMARCA4 (BRG1)-Deficient Carcinoma: Report of A Case Diagnosed by Pleural Effusion Cytology initially |
|
|||
11:04-11:12 | 发言交流 |
Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma |
|
|||
11:12-11:20 | 发言交流 |
尿液肿瘤标志物在尿路上皮癌中的分子研究 |
|
|||
11:20-11:28 | 发言交流 |
细胞学在神经组织术中快速诊断的应用 |
|
|||
11:28-11:40 | 总结 |
总结 |
|